Evident Acquires CrestOptics S.p.A.

Evident Acquires Pramana, Inc.

November 7, 2025

Medical Devices

Evident has completed its acquisition of Pramana, Inc., a Cambridge-based developer of autonomous whole slide imaging systems for digital pathology. The deal brings Pramana's AI-powered imaging and workflow technology into Evident's microscopy and optical-imaging portfolio to accelerate digital pathology capabilities and broaden solutions for hospitals, research institutions, and laboratories.

Xpansiv Limited Acquires Evident Group Limited

November 4, 2025

Energy

Xpansiv Limited has wholly acquired Evident Group Limited, combining Evident's international I-REC(E) and other registries with Xpansiv's North American Renewables Registry (NAR) and TIGR to create a leading global renewable energy certificate (REC) registry network. The deal expands Xpansiv's global registry and certification capabilities, creating an integrated platform with over 300 GW of registered capacity and more than 4,000 participating companies.

Wabtec Acquires Evident Inspection Technologies Division for $1.78 Billion

July 1, 2025

Industrial Services

Wabtec Corporation entered into and completed the acquisition of Evident's Inspection Technologies division for $1.78 billion, strengthening Wabtec’s Digital Intelligence business. The deal expands advanced automated inspection capabilities, adds a recurring revenue base, and broadens Wabtec’s reach across rail, mining, and other industrial end-markets.

Buenavista Equity Partners (via Evidenze) Acquires Chrestos Concept GmbH & Co. KG

November 22, 2024

Healthcare Services

Buenavista Equity Partners has acquired German CRO Chrestos Concept GmbH & Co. KG through its healthcare platform Evidenze Group Europe. The add-on expands Evidenze's capabilities in clinical trial design, biostatistics and data science and strengthens its presence in Germany as part of a buy-and-build strategy.

Bain Capital Private Equity Acquires Evident (formerly Olympus Scientific Solutions) from Olympus Corporation

August 29, 2022

Medical Devices

Bain Capital Private Equity has signed a definitive agreement to acquire Evident Corporation (formerly Olympus Scientific Solutions) from Olympus Corporation. Evident, a global manufacturer of microscopes, videoscopes and non-destructive testing equipment for life science and industrial markets, will operate as an independent company with Bain supporting expansion of digital products, workflow integration and automation; the deal was expected to close in Q1 2023 subject to regulatory approvals.

Bain Capital Private Equity Acquires Evident Corporation from Olympus

April 3, 2022

Medical Devices

Bain Capital Private Equity has completed the acquisition of Evident Corporation (formerly the Scientific Solutions Division of Olympus) following regulatory approvals. The deal creates an independent company focused on microscopes, imaging and non-destructive testing equipment, with Bain supporting product innovation and global expansion.